共 99 条
[1]
Glen J(2016)Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance BMJ 354 i4428-71
[2]
Floros L(2013)Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease Hepatol Int 7 65-811
[3]
Day C(2017)Consensus on integrative medical diagnosis and treatment of non-alcoholic fatty liver disease Chin J Integr Tradit West Med Digest 25 805-84
[4]
Pryke R(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-122
[5]
Wah-Kheong C(2013)Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals Ann N Y Acad Sci 1281 106-S64
[6]
Khean-Lee G(2015)NAFLD: a multisystem disease J Hepatol 62 S47-1144
[7]
Li J(2016)EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate? Diabetologia 59 1141-121
[8]
Chen J(2005)The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 113-357
[9]
Wang Y(2018)The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-4761
[10]
Younossi ZM(2006)Review: The role of insulin resistance in nonalcoholic fatty liver disease J Clin Endocrinol Metab 91 4753-101